Gain Therapeutics
GANX
GANX
21 hedge funds and large institutions have $3.74M invested in Gain Therapeutics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$62.6K | |
| 2 | +$39.9K | |
| 3 | +$9.91K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.72K |
| 5 |
BlackRock
New York
|
+$6.51K |
Top Sellers
| 1 | -$84.5K | |
| 2 | -$46.9K | |
| 3 | -$19.6K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$923 |